pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Midterm voters weigh health-care costs as urgent-care visits billed like ERs

Nov 2, 2026·read at STAT ↗Negative

The upcoming midterm elections will see tens of millions of voters consider health‑care affordability, especially those whose coverage comes through their employers. The article points out that rising out‑of‑pocket expenses are a key factor shaping voter sentiment.

A specific concern highlighted is the practice of billing urgent‑care visits at the same rates as emergency‑room services, which can leave patients with unexpectedly large bills. This billing approach adds to the overall financial strain on individuals seeking timely care.

The story appears in STAT’s Health Care Inc. newsletter, emphasizing that these cost pressures could influence voting decisions and broader discussions about health‑care policy.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The health care affordability midterms, and billing urgent care as ER”

read at STAT ↗
477 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISINGUltragenyx Pharmaceutical Inc.
drugs
(aeruginascin + baeocystin + psilocybin)MYCO-003Oral PsilocybinPsilocybin (Microneedle Patch)psilocybin
topics
PainRare Disease

related stories

  • Sep 14Psychedelic therapies ride wave of public favor into FDA hearingBioSpace
  • Jul 18‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelicsFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Oct 15Compass Pathways CEO: Psychedelics company will ‘go slow before we go fast’STAT
  • Sep 16Deep dive: Psychedelics back on FDA’s doorstepBioSpace